A case of fulminant hepatic failure in pregnancy
John Halliday, Julie Lokan, Peter W. Angus, Paul Gow – 23 December 2009
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: Update 2009
Thomas D. Boyer, Ziv J. Haskal – 23 December 2009
Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box
Chia‐Chi Wang, Jia‐Horng Kao – 23 December 2009
Minocycline protects against the mitochondria permeability transition after both warm and cold ischemia‐reperfusion
Xun Zhang, Justin Schwartz, Venkat K. Ramshesh, Peter Pediaditakis, Ekhson Holmuhamedov, Zhi Zhong, Tom P. Theruvath, John J. Lemasters – 23 December 2009
Lipidomic dissection of nonalcoholic steatohepatitis: Moving beyond foie gras to fat traffic
Nathan M. Bass – 23 December 2009
Kupffer cell and interleukin‐12–dependent loss of natural killer T cells in hepatosteatosis
Michael Kremer, Emmanuel Thomas, Richard J. Milton, Ashley W. Perry, Nico van Rooijen, Michael D. Wheeler, Steven Zacks, Michael Fried, Richard A. Rippe, Ian N. Hines – 23 December 2009 – Hepatosteatosis is associated with increased expression of tumor necrosis factor alpha (TNF‐α) and interleukin (IL)‐12, major T helper (Th) 1 cytokines, and reduced hepatic natural killer T (NKT) cell numbers. The relationship between lipid accumulation, cytokine expression, and hepatic NKT cells is not known.
N‐acetylcysteine on its way to a broader application in patients with acute liver failure
Alexander Koch, Christian Trautwein – 23 December 2009
Fluorescent in situ hybridization testing in primary sclerosing cholangitis: Useful testing or a random chance result?
William C. Chapman – 23 December 2009
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells
Michelina Nascimbeni, Thomas Montange, Helen K. W. Law, Vincent Mallet, Bertrand Saunier, Yves Rivière, Stanislas Pol – 23 December 2009
Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B
Ji‐Yuan Zhang, Zheng Zhang, Fang Lin, Zheng‐Sheng Zou, Ruo‐Nan Xu, Lei Jin, Jun‐Liang Fu, Feng Shi, Ming Shi, Hui‐Fen Wang, Fu‐Sheng Wang – 23 December 2009 – Interleukin‐17 (IL‐17)‐producing CD4+ T cells (Th17)‐mediated immune response has been demonstrated to play a critical role in inflammation‐associated disease; however, its role in chronic hepatitis B virus (HBV) infection remains unknown.